Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
There is currently no completely effective therapy available for metastatic pheochromocytomas or paragangliomas. Increasing understanding of the germline and somatic mutations leading to pheochromocytoma and paraganglioma development has revealed crucial insights into the molecular pathology of thes...
Príomhchruthaitheoirí: | Nölting, S, Grossman, AB |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2012
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Pheochromocytomas and paragangliomas: assessment of malignant potential.
de réir: Korevaar, T, et al.
Foilsithe / Cruthaithe: (2011) -
Pheochromocytomas and paragangliomas: assessment of malignant potential
de réir: Korevaar, T, et al.
Foilsithe / Cruthaithe: (2011) -
Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine
de réir: Nölting, S, et al.
Foilsithe / Cruthaithe: (2019) -
Pheochromocytomas and secreting paragangliomas
de réir: Gimenez-Roqueplo Anne-Paule, et al.
Foilsithe / Cruthaithe: (2006-12-01) -
Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
de réir: Kaltsas, G, et al.
Foilsithe / Cruthaithe: (2003)